loading
Precedente Chiudi:
$7.82
Aprire:
$7.71
Volume 24 ore:
2.21M
Relative Volume:
1.73
Capitalizzazione di mercato:
$509.41M
Reddito:
-
Utile/perdita netta:
$-297.11M
Rapporto P/E:
-1.7009
EPS:
-4.38
Flusso di cassa netto:
$-216.95M
1 W Prestazione:
-5.58%
1M Prestazione:
-14.66%
6M Prestazione:
-36.92%
1 anno Prestazione:
-9.26%
Intervallo 1D:
Value
$7.39
$7.8299
Intervallo di 1 settimana:
Value
$7.39
$8.60
Portata 52W:
Value
$6.065
$19.71

Phathom Pharmaceuticals Inc Stock (PHAT) Company Profile

Name
Nome
Phathom Pharmaceuticals Inc
Name
Telefono
(877) 742-8466
Name
Indirizzo
100 CAMPUS DRIVE,, FLORHAM PARK, NJ
Name
Dipendente
112
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
PHAT's Discussions on Twitter

Confronta PHAT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
PHAT
Phathom Pharmaceuticals Inc
7.45 509.41M 0 -297.11M -216.95M -5.19
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
397.27 102.31B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
701.85 77.13B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
623.82 37.30B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
245.44 31.66B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
113.08 27.11B 3.30B -501.07M 1.03B -2.1146

Phathom Pharmaceuticals Inc Stock (PHAT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-05-03 Iniziato Stifel Buy
2024-01-05 Reiterato Needham Buy
2023-08-09 Iniziato H.C. Wainwright Buy
2023-05-11 Aggiornamento Evercore ISI In-line → Outperform
2023-03-13 Iniziato Craig Hallum Buy
2022-10-21 Iniziato Jefferies Buy
2022-05-06 Downgrade Evercore ISI Outperform → In-line
2021-05-12 Aggiornamento Goldman Sell → Neutral
2021-02-17 Iniziato BMO Capital Markets Outperform
2021-02-02 Iniziato Guggenheim Buy
2020-06-26 Downgrade Goldman Neutral → Sell
2019-11-20 Iniziato Evercore ISI Outperform
2019-11-19 Iniziato Goldman Neutral
2019-11-19 Iniziato Jefferies Buy
2019-11-19 Iniziato Needham Buy
Mostra tutto

Phathom Pharmaceuticals Inc Borsa (PHAT) Ultime notizie

pulisher
Dec 20, 2024

Phathom Pharmaceuticals CFO Molly Henderson sells $10,328 in stock - Investing.com India

Dec 20, 2024
pulisher
Dec 20, 2024

Insider Selling: Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) CFO Sells 1,291 Shares of Stock - MarketBeat

Dec 20, 2024
pulisher
Dec 20, 2024

Phathom Pharmaceuticals COO sells shares for $8,944 - Investing.com

Dec 20, 2024
pulisher
Dec 20, 2024

Phathom Pharmaceuticals (NASDAQ:PHAT) Stock Price Down 2%What's Next? - MarketBeat

Dec 20, 2024
pulisher
Dec 20, 2024

Phathom Pharmaceuticals Inc (PHAT) Recovers 28.94% From Low: Are We There Yet? - Stocks Register

Dec 20, 2024
pulisher
Dec 17, 2024

FDA Tracker: FDA Hands Out Atopic Dermatitis Approvals to Galderma, Organon - BioSpace

Dec 17, 2024
pulisher
Dec 17, 2024

Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Gap Up After Insider Buying Activity - Defense World

Dec 17, 2024
pulisher
Dec 17, 2024

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

Dec 17, 2024
pulisher
Dec 17, 2024

Frank Karbe buys $99,083 in Phathom Pharmaceuticals stock By Investing.com - Investing.com Australia

Dec 17, 2024
pulisher
Dec 16, 2024

Frank Karbe buys $99,083 in Phathom Pharmaceuticals stock - Investing.com India

Dec 16, 2024
pulisher
Dec 16, 2024

Phathom Pharmaceuticals director Asit Parikh buys $81,248 in stock By Investing.com - Investing.com South Africa

Dec 16, 2024
pulisher
Dec 16, 2024

How To Trade (PHAT) - Stock Traders Daily

Dec 16, 2024
pulisher
Dec 16, 2024

Insider Buying: Asit Parikh Acquires 10,000 Shares of Phathom Ph - GuruFocus.com

Dec 16, 2024
pulisher
Dec 16, 2024

Frank Karbe Increases Stake in Phathom Pharmaceuticals Inc (PHAT) - GuruFocus.com

Dec 16, 2024
pulisher
Dec 16, 2024

Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Gap Up on Insider Buying Activity - MarketBeat

Dec 16, 2024
pulisher
Dec 16, 2024

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Director Acquires $99,125.00 in Stock - MarketBeat

Dec 16, 2024
pulisher
Dec 16, 2024

Phathom Pharmaceuticals director Asit Parikh buys $81,248 in stock - Investing.com

Dec 16, 2024
pulisher
Dec 14, 2024

Insider Sellers Might Regret Selling Phathom Pharmaceuticals Shares at a Lower Price Than Current Market Value - Simply Wall St

Dec 14, 2024
pulisher
Dec 13, 2024

Charles Schwab Investment Management Inc. Purchases 6,990 Shares of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - Defense World

Dec 13, 2024
pulisher
Dec 13, 2024

Phathom Pharmaceuticals Submits Citizen Petition to FDA for Correction of Orange Book Listings for VOQUEZNA Tablets - Defense World

Dec 13, 2024
pulisher
Dec 12, 2024

Phathom Pharma shares stay Buy rated on extended vonoprazan exclusivity to 2032 - Investing.com Canada

Dec 12, 2024
pulisher
Dec 12, 2024

Do You Believe in the Growth Potential of Phathom Pharmaceuticals (PHAT)? - MSN

Dec 12, 2024
pulisher
Dec 12, 2024

Phathom Pharmaceuticals (NASDAQ:PHAT) Receives "Buy" Rating from HC Wainwright - MarketBeat

Dec 12, 2024
pulisher
Dec 11, 2024

Phathom Pharmaceuticals: The Large Drop Is, Well, Unfathomable (NASDAQ:PHAT) - Seeking Alpha

Dec 11, 2024
pulisher
Dec 11, 2024

Phathom Pharmaceuticals seeks FDA clarity on drug exclusivity - Investing.com

Dec 11, 2024
pulisher
Dec 11, 2024

Phathom Pharmaceuticals seeks FDA clarity on drug exclusivity By Investing.com - Investing.com UK

Dec 11, 2024
pulisher
Dec 11, 2024

Phathom Pharmaceuticals Submits Citizen Petition to FDA Seeking Correction of Orange Book Listings for VOQUEZNA® (vonoprazan) Tablets - The Manila Times

Dec 11, 2024
pulisher
Dec 11, 2024

Phathom Pharmaceuticals Submits Citizen Petition to FDA - GlobeNewswire

Dec 11, 2024
pulisher
Dec 10, 2024

Fmr LLC Boosts Stock Holdings in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - MarketBeat

Dec 10, 2024
pulisher
Dec 09, 2024

Down -54.05% in 4 Weeks, Here's Why Phathom Pharmaceuticals (PHAT) Looks Ripe for a Turnaround - MSN

Dec 09, 2024
pulisher
Dec 08, 2024

Point72 Asset Management L.P. Takes Position in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - MarketBeat

Dec 08, 2024
pulisher
Dec 01, 2024

Wasatch Advisors LP Buys Shares of 246,942 Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - MarketBeat

Dec 01, 2024
pulisher
Nov 30, 2024

Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Down 3.5%Should You Sell? - MarketBeat

Nov 30, 2024
pulisher
Nov 30, 2024

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Short Interest Update - MarketBeat

Nov 30, 2024
pulisher
Nov 25, 2024

Eagle Asset Management Inc. Increases Stock Position in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - MarketBeat

Nov 25, 2024
pulisher
Nov 25, 2024

(PHAT) Technical Pivots with Risk Controls - Stock Traders Daily

Nov 25, 2024
pulisher
Nov 23, 2024

Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Gap DownTime to Sell? - MarketBeat

Nov 23, 2024
pulisher
Nov 21, 2024

Jennison Associates LLC Has $106.06 Million Position in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - MarketBeat

Nov 21, 2024
pulisher
Nov 20, 2024

Phathom Pharmaceuticals (PHAT) Upgraded to Buy: Here's What You Should Know - MSN

Nov 20, 2024
pulisher
Nov 19, 2024

Phathom Pharmaceuticals - The Healthcare Technology Report.

Nov 19, 2024
pulisher
Nov 14, 2024

(PHAT) Proactive Strategies - Stock Traders Daily

Nov 14, 2024
pulisher
Nov 11, 2024

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 11, 2024
pulisher
Nov 11, 2024

Phathom Pharmaceuticals Inc (NASDAQ: PHAT) Up 115.60% This Year: What Is Going To Happen Next - Stocks Register

Nov 11, 2024
pulisher
Nov 11, 2024

Phathom Pharmaceuticals Reports Strong Third Quarter 2024 Financial Results and Business Updates - Defense World

Nov 11, 2024
pulisher
Nov 09, 2024

Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Down 8.9%Here's What Happened - MarketBeat

Nov 09, 2024
pulisher
Nov 08, 2024

Phathom Pharmaceuticals, Inc. (PHAT) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 08, 2024
pulisher
Nov 08, 2024

Phathom Pharmaceuticals Inc (PHAT) Q3 2024 Earnings Call Highlig - GuruFocus.com

Nov 08, 2024
pulisher
Nov 08, 2024

Phathom Pharmaceuticals Inc (PHAT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance

Nov 08, 2024

Phathom Pharmaceuticals Inc Azioni (PHAT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Phathom Pharmaceuticals Inc Azioni (PHAT) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Henderson Molly
CFO and CBO
Dec 19 '24
Sale
8.00
1,291
10,328
98,156
KARBE FRANK
Director
Dec 13 '24
Buy
7.93
12,500
99,084
57,000
Parikh Asit
Director
Dec 13 '24
Buy
8.12
10,000
81,248
75,500
Nabulsi Azmi
Chief Operating Officer
Jul 15 '24
Sale
11.72
10,901
127,760
240,421
Henderson Molly
CFO and CBO
Jul 15 '24
Sale
11.72
4,325
50,689
99,447
Curran Terrie
President and Chief Executive
Jul 15 '24
Sale
11.72
33,848
396,699
377,734
Henderson Molly
CFO and CBO
Apr 08 '24
Sale
11.10
3,435
38,128
95,263
Curran Terrie
President and Chief Executive
Mar 22 '24
Sale
9.11
16,851
153,513
410,784
TAKEDA PHARMACEUTICAL CO LTD
10% Owner
Jan 24 '24
Sale
8.10
3,703,703
29,999,994
3,755,583
Henderson Molly
CFO and CBO
Jan 19 '24
Sale
7.75
6,307
48,900
98,698
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Capitalizzazione:     |  Volume (24 ore):